SCHEMBL12313246

SCHEMBL12313246

Cc1cccc(-c2ccc3cc(-n4cccc4)c(-n4cccc4)cc3n2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 3/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ BCHE P06276 1/20 0.39
▸ ACHE P22303 1/20 0.39
▸ KMO O15229 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ ENPP3 O14638 1/20 0.38
▸ IDO1 P14902 1/20 0.38
▸ METAP2 P50579 1/20 0.38
▸ GRM2 Q14416 1/20 0.37
▸ XDH P47989 1/20 0.37
▸ MAOA P21397 1/20 0.36
▸ MAOB P27338 1/20 0.36
▸ MET P08581 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36
▸ RELA Q04206 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12313249 0.92 RAB9A (0.41) RAB9ANPC1KDM4EBCHEACHE
SCHEMBL12313235 0.92 RAB9A (0.41) RAB9ANPC1KDM4EBCHEACHE
SCHEMBL12313247 0.88 IGF1R (0.37) RAB9ANPC1KDM4ESMN1; SMN2MAOA
SCHEMBL12313256 0.83 NPC1 (0.46) RAB9ANPC1KDM4ESMN1; SMN2MAOA
SCHEMBL12313219 0.83 MAOA (0.42) RAB9ANPC1KDM4EBCHEACHE
SCHEMBL12313254 0.82 MAP4K4 (0.46) RAB9ANPC1KDM4ESMN1; SMN2MAOA
SCHEMBL3408047 0.82 MAOA (0.53) RAB9ANPC1KDM4EBCHEACHE
SCHEMBL12313248 0.80 IGF1R (0.36) RAB9ANPC1KDM4EMAOAMAOB
SCHEMBL12313237 0.80 IGF1R (0.36) RAB9ANPC1KDM4ESMN1; SMN2MAOA
SCHEMBL13399635 0.79 BCHE (0.42) RAB9ANPC1KDM4EBCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8263237-B2 Red phosphorescent composition and organic electroluminescent device using the same LG DISPLAY CO., LTD (KR) 2012-09-11 — — US disclosed
US-8263237-B2 Red phosphorescent composition and organic electroluminescent device using the same LG DISPLAY CO., LTD (KR) 2012-09-11 — — US disclosed
US-20100102714-A1 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2010-04-29 — — US disclosed
US-20100102714-A1 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2010-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100102714-A1 Red phosphorescent compound and organic electroluminescent device using the same YTHDC1, IK, PYCR1 RAB9A 171/4885NPC1 2402/4885KDM4E 1684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback